Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind comparison of beclometasone/formoterol inhalation aerosol versus FOSTER in adults with asthma
CTR20260900Phase 3Active
- Sponsor
- Lunan Better Pharmaceutical Co., Ltd.
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Lunan Better Pharmaceutical Co., Ltd.. Started Jun 2026; status: active.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20260900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260900.